Cresilon Partners with McCarthy Vet to Distribute VETIGEL in Canada
Cresilon Inc., a biotechnology pioneer based in Brooklyn, has made waves in the veterinary industry by announcing a strategic distribution agreement with McCarthy Vet. This partnership introduces VETIGEL®, a game-changing plant-based hemostatic gel, to veterinary practitioners across Canada. McCarthy Vet is a full-service supplier that has been dedicated to serving veterinarians in the Canadian animal health sector for over 60 years.
VETIGEL is designed to instantly halt and control bleeding during a variety of surgical procedures. Since its launch in 2021, this innovative product has gained popularity amongst veterinary surgeons in North America, Europe, and Asia, establishing itself as the go-to option for effectively managing traumatic wounds and a wide range of surgical interventions. It boasts an extensive track record, having assisted in over 60,000 surgical procedures worldwide, making it an invaluable addition to veterinary clinics.
The product is tailored to enhance veterinary care by allowing surgeries to proceed with reduced bleeding complication risks, which can lead to decreased operation times and improved patient outcomes. Brittany Boysen, the National Sales Manager for VETIGEL, stated, "Our collaboration with McCarthy Vet will enable us to reach more veterinary surgeons, providing them with this innovative hemostatic gel that enhances the quality of care for animals."
VETIGEL is not only effective but also user-friendly. It comes in a pre-filled syringe format, requiring no special preparation or storage conditions, making it accessible for everyday use in veterinary practices. The gel is biocompatible and non-animal derived, utilizing a unique blend of plant polymers that creates an instant mechanical barrier to stop bleeding on contact. Once hemostasis is achieved, VETIGEL can be easily removed without disrupting the underlying clot or can be left in the body to naturally resorb.
This advancement is significant for McCarthy Vet as they continue to add leading-edge products to their portfolio, emphasizing their commitment to providing the veterinary community with the latest innovations that enhance clinical effectiveness and patient care. McCarthy Vet representatives are dedicated to ensuring veterinarians across all provinces have access to the most advanced veterinary supplies, solidifying their role as a key player in the Canadian veterinary landscape.
Cresilon stands out in the biotechnology field, especially for its promise of saving lives through innovative hemostatic solutions. The company focuses not only on veterinary applications but also on trauma care and biosurgery. Their proprietary hydrogel technology, which has earned them a spot on Fast Company's list of the World's Most Innovative Companies for 2024, is revolutionizing how bleeding is managed in medical settings.
Veterinary practices equipped with VETIGEL stand to gain not only in terms of surgical efficiency but also in enhanced patient safety and care quality, marking a pivotal change in veterinary medicine standards. For more detailed information, those interested can visit Cresilon's official site at cresilon.com or McCarthy Vet's site at mccarthyvet.com. This partnership not only highlights Cresilon's dedication to veterinary innovation but reinforces the importance of collaborative efforts to advance animal healthcare significantly.
VETIGEL is designed to instantly halt and control bleeding during a variety of surgical procedures. Since its launch in 2021, this innovative product has gained popularity amongst veterinary surgeons in North America, Europe, and Asia, establishing itself as the go-to option for effectively managing traumatic wounds and a wide range of surgical interventions. It boasts an extensive track record, having assisted in over 60,000 surgical procedures worldwide, making it an invaluable addition to veterinary clinics.
The product is tailored to enhance veterinary care by allowing surgeries to proceed with reduced bleeding complication risks, which can lead to decreased operation times and improved patient outcomes. Brittany Boysen, the National Sales Manager for VETIGEL, stated, "Our collaboration with McCarthy Vet will enable us to reach more veterinary surgeons, providing them with this innovative hemostatic gel that enhances the quality of care for animals."
VETIGEL is not only effective but also user-friendly. It comes in a pre-filled syringe format, requiring no special preparation or storage conditions, making it accessible for everyday use in veterinary practices. The gel is biocompatible and non-animal derived, utilizing a unique blend of plant polymers that creates an instant mechanical barrier to stop bleeding on contact. Once hemostasis is achieved, VETIGEL can be easily removed without disrupting the underlying clot or can be left in the body to naturally resorb.
This advancement is significant for McCarthy Vet as they continue to add leading-edge products to their portfolio, emphasizing their commitment to providing the veterinary community with the latest innovations that enhance clinical effectiveness and patient care. McCarthy Vet representatives are dedicated to ensuring veterinarians across all provinces have access to the most advanced veterinary supplies, solidifying their role as a key player in the Canadian veterinary landscape.
Cresilon stands out in the biotechnology field, especially for its promise of saving lives through innovative hemostatic solutions. The company focuses not only on veterinary applications but also on trauma care and biosurgery. Their proprietary hydrogel technology, which has earned them a spot on Fast Company's list of the World's Most Innovative Companies for 2024, is revolutionizing how bleeding is managed in medical settings.
Veterinary practices equipped with VETIGEL stand to gain not only in terms of surgical efficiency but also in enhanced patient safety and care quality, marking a pivotal change in veterinary medicine standards. For more detailed information, those interested can visit Cresilon's official site at cresilon.com or McCarthy Vet's site at mccarthyvet.com. This partnership not only highlights Cresilon's dedication to veterinary innovation but reinforces the importance of collaborative efforts to advance animal healthcare significantly.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.